Level of tumor-infiltrating lymphocytes and density of infiltrating immune cells in different malignancies
- Carlos A. Castaneda(corresponding author),
- Miluska Castillo,
- Karina Aliaga,
- Luis A. Bernabe,
- Sandro Casavilca,
- Joselyn Sanchez
- ,
- Universidad Científica del Sur,
- Instituto Nacional de Enfermedades Neoplásicas,
- The University of Texas M.D. Anderson Cancer Center
Publication Information
Output type
Original language
EnglishPages from-to (Number of pages)
Pages 1481-1491 (11 pages)Journal (Volume, Issue Number)
Biomarkers in Medicine (Volume 13, Issue 17)Publication milestones
- Published - 2019
Publication status
ISSN
1752-0363Publication IDs
- Scopus: 85074446280
- PubMed: 31621387
Abstract
Aim: To correlate levels of tumor-infiltrating lymphocytes (TIL) evaluated using the International Immuno-Oncology Biomarker Working Group methodology, and both density of tumor-infiltrating immune cell and clinicopathological features in different malignancies. Methods: 209 pathological samples from gastric cancer, cervical cancer (CC), non-small-lung cancer, cutaneous melanoma (CM) and glioblastoma were tested for TIL in hematoxylin eosin, and density of CD3+, CD4+, CD8+, CD20+, CD68+ and CD163+ cells by digital analysis. Results: TIL levels were higher in invasive margin compartments (IMC). TIL in IMC, intratumoral and stromal compartments predicted survival. CC and gastric cancer had higher TIL in intratumoral; CC and CM had higher TIL in stromal compartment and IMC. CM had the highest density of lymphocyte and macrophage populations. CD20 density was associated with survival in the whole series. Conclusion: Standardized evaluation of TIL levels may provide valuable prognostic information in a spectrum of different malignancies.
Funding Details
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
